Global Pressure Infusion Bags Market Outlook, 2031

The global pressure infusion bags market has emerged as a critical segment within the medical devices industry, providing essential tools for the rapid and controlled administration of intravenous fluids, blood products, and medications in emergency and surgical settings. These devices apply consistent pressure to infusion bags, ensuring fluids are delivered at a controlled rate when gravity-fed IV systems are insufficient, particularly in trauma care, severe dehydration, and during massive transfusions. The ability to provide a stable and adjustable pressure environment helps prevent complications such as air embolism or inconsistent flow rates that can occur with other infusion methods.

According to the research report " Global Pressure Infusion Bags Market Outlook, 2031," published by Bonafide Research, the Global Pressure Infusion Bags was valued at USD 362 Million in 2025. The market is experiencing significant transformation driven by the increasing prevalence of chronic diseases and trauma cases worldwide, rising surgical volumes, and the growing emphasis on infection control in healthcare settings. Technological advancements, including the integration of smart monitoring capabilities, digital pressure gauges, and safety valves, are enhancing the safety and efficiency of these devices. The shift toward disposable pressure infusion bags is gaining momentum as healthcare facilities prioritize infection prevention and seek to reduce cross-contamination risks.

Drivers Rising prevalence of chronic diseases and trauma cases: The increasing incidence of chronic conditions requiring intravenous therapy and the growing number of emergency transfusion cases are primary drivers for the pressure infusion bags market.

Rapid adoption of disposable bags in OR and ED: The shift toward disposable pressure infusion bags is accelerating as hospital infection-control committees favor single-use bags following outbreaks linked to inadequately reprocessed reusable cuffs.

Challenges Shortage of skilled infusion therapists in low-income regions: The shortage of trained healthcare professionals capable of operating advanced pressure infusion systems limits market penetration in developing regions.



Stringent ISO compliance costs and raw material volatility: Updating manufacturing facilities to meet ISO 8536-8's tighter particulate and pressure compliance thresholds can push testing expenses to 3-5% of device revenues for mid-size manufacturers.

Trends Technological shift to integrated pressure-monitoring valves and smart features: Healthcare providers are increasingly seeking pressure infusion bags with embedded sensors and advanced digital gauges enabling automated pressure regulation.

Sustainability push for PVC-free and eco-friendly bag materials: The market is witnessing a significant shift toward PVC-free biopolymers, powered by EU directives phasing out DEHP-containing PVC in clinical environments.

The market is segmented by product type into reusable and disposable pressure infusion bags, with disposable bags currently holding the dominant market share due to infection control priorities. Disposable pressure infusion bags anchoring the market's infection-control priority. This substantial market share reflects rising legal liability from hospital-acquired infections alongside payor penalties, making disposables the preferred choice in operating rooms and emergency departments. Under these dynamics, the disposable segment steadily replacing reusable cuffs even in cost-sensitive regions. The shift toward disposable products is driven by the growing emphasis on minimizing cross-contamination risks, eliminating the need for cleaning and sterilization between uses, and reducing labor costs associated with reprocessing. During multi-casualty drills, emergency departments reported 20% faster turnover when disposables were pre-assembled on trauma carts, highlighting their operational efficiency benefits. Reusable pressure infusion bags, while representing a smaller share, continue to serve cost-conscious healthcare facilities where infection risks are lower and budgets are constrained. However, manufacturers are automating production to narrow unit-cost differentials while maintaining quality assurance, making disposables increasingly accessible across all healthcare settings.

The market is segmented by material into nylon, polyurethane, and others, with nylon currently holding the largest share, while PVC-free alternatives are emerging as the fastest-growing segment. Nylon accounted its established biocompatibility, favorable price-performance ratio, and proven durability in medical applications. Nylon-based pressure infusion bags have been widely adopted due to their resistance to wear and tear, ensuring they can withstand repeated use without compromising performance.This sustainability-driven momentum positions PVC-free variants as the fastest-growing material segment in the pressure infusion bags market. Sustainability teams at university hospitals increasingly specify bio-polyurethane bags in tenders, citing lifecycle-carbon savings and lower incineration emissions. Suppliers are diversifying feedstocks away from volatile nylon streams to hedge geopolitical risk and stabilize cost structures while promoting green-label credentials. Polyurethane materials are gaining traction for their superior flexibility, biocompatibility, and ability to incorporate advanced safety features such as integrated pressure gauges and safety valves. The others segment includes silicone-coated composites and latex-free alternatives, catering to specialized clinical requirements where specific material properties are needed for patient safety and device performance.

The market is segmented by application into blood and drug infusion and invasive pressure monitoring procedures, with blood and drug infusion representing the dominant application segment. Blood and drug infusion anchoring daily inpatient usage and underpinning the largest slice of the pressure infusion bags market. This application segment encompasses rapid fluid resuscitation, intravenous therapy, medication delivery, and transfusion procedures where controlled pressure is essential to maintain consistent flow rates and prevent complications such as air embolism or inconsistent delivery. The increasing prevalence of chronic diseases requiring intravenous therapy, such as cancer, diabetes, and cardiovascular conditions, is driving sustained demand for pressure infusion bags in blood and drug infusion applications.. Invasive pressure monitoring procedures represent a significant application segment where pressure infusion bags are used to maintain accurate pressure readings in arterial and central venous pressure monitoring. The integration of pressure infusion bags with monitoring equipment ensures stable pressure environments, enhancing the accuracy of hemodynamic measurements. The growing adoption of minimally invasive procedures and the expansion of intensive care units are supporting demand in this segment.

The market is segmented by end user into hospitals and clinics, outpatient facilities, and others, with hospitals and clinics representing the largest end-user segment. Hospitals and clinics capitalizing on multi-departmental consumption across emergency departments, operating rooms, intensive care units, and general wards. The increasing number of surgical procedures, emergency medical cases, and critical care admissions in hospitals worldwide is driving sustained demand for pressure infusion bags in this segment. Hospitals serve as the primary adoption channel for pressure infusion bags due to the high volume of rapid fluid and drug administration in emergency, critical, and surgical settings, where reliable infusion delivery is critical for patient outcomes. Outpatient facilities, including ambulatory surgical centers and home healthcare settings, represent the fastest-growing end-user segment, As more patients receive care outside of traditional hospital environments, there is a growing need for portable, easy-to-use infusion solutions that can be safely administered by non-professional caregivers. Ambulatory surgical centers are increasingly purchasing compact, portable units that match fast-turnover schedules without compromising safety, while home-care programs adopt backpack-compatible pressure cuffs for infusion of specialty biologics in community settings. The others segment includes disaster-response agencies and military medicine settings, where ruggedized bags rated for temperature extremes provide mission-critical support in field hospitals, reinforcing niche but strategically important demand clusters.

North America leads the global pressure infusion bags market, driven by premium reimbursement structures, advanced healthcare infrastructure, and rapid adoption of smart infusion technologies. North America leads the global pressure infusion bags market underpinned by premium reimbursement structures, strong military medical budgets, and rapid adoption of smart infusion technologies. The United States represents the primary growth engine, with major manufacturers including BD, Smiths Medical, and Merit Medical Systems driving continuous innovation in sensor technology and device connectivity. U.S. buyers benefit from bundled payment incentives that reward shorter ICU stays, encouraging investment in devices that reduce infusion-related complications. Canada's national procurement initiatives are likewise pivoting toward disposable, PVC-free alternatives, aligning with federal environmental targets. The region's advanced healthcare infrastructure, well-established distribution networks, and high awareness of infection control benefits ensure continued market leadership.

In 2025 — Disposable pressure infusion bags held 69.22% of the market share, driven by infection-control priorities and operational efficiency in emergency departments.

In 2025 — PVC-free biopolymer alternatives emerged as the fastest-growing material segment fueled by EU directives phasing out DEHP-containing PVC in clinical environments.

In 2025 — The 301-400 mmHg pressure range segment recorded the highest reflecting more aggressive trauma-resuscitation algorithms.

In 2024 — Smart pressure infusion systems with integrated monitoring valves gained traction, with clinical trials showing real-time pressure sensing cut alarm response times by over 40 seconds.


Considered in this report
• Historic Year: 2020
• Base Year: 2025
• Estimated Year: 2026
• Forecast Year: 2031

Aspects covered in this report
• Global Pressure Infusion Bags Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Reusable
• Disposable

By Material
• Nylon
• Polyurethane (PU)
• Others

By Application
• Blood and Drug Infusion
• Invasive Pressure Monitoring Procedures

By End User
• Hospitals and Clinics
• Outpatient Facilities
• Others